Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001104659-25-064897
Filing Date
2025-07-02
Accepted
2025-07-01 19:45:51
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B4 tm2516057d7_424b4.htm 424B4 573882
2 GRAPHIC tm2516057d3_s1img001.jpg GRAPHIC 37271
  Complete submission text file 0001104659-25-064897.txt   626560
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-288333 | Film No.: 251098004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)